NEW DELHI, Jul 9: A key parliamentary panel has proposed a major expansion of India’s flagship public health insurance programme, recommending that the annual coverage available under Ayushman Bharat be raised from ₹5 lakh to ₹10 lakh per family. The suggestion comes amid persistent concern over the high medical expenses borne directly by households and renewed debate over whether India’s existing financial protection architecture is sufficient to shield vulnerable families from catastrophic health spending.
The recommendation, made by the Parliamentary Standing Committee on Health and Family Welfare, has reopened a wider policy conversation on the future of publicly funded healthcare in India. At the heart of the panel’s observation is a simple concern: while the country has expanded health insurance access, millions of families still face heavy treatment costs for serious illnesses, long hospital stays, surgeries, cancer care, cardiac procedures, and post-hospitalisation expenses that often go beyond the limits of available coverage.
Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana, commonly known as AB-PMJAY, was launched as the Centre’s flagship health protection scheme for economically weaker sections. It currently provides health insurance cover of up to ₹5 lakh per eligible family per year for secondary and tertiary hospitalisation. The scheme was conceived as a major intervention to reduce out-of-pocket expenditure and improve access to hospital care among poor and vulnerable households. Over the years, it has grown into one of the world’s largest publicly funded health insurance programmes in terms of intended beneficiary base.
However, as the health system evolves and treatment costs continue to rise, policymakers and public health experts have increasingly questioned whether the present ceiling is adequate for a country dealing with a dual burden of disease—infectious illnesses on one hand and a sharp rise in chronic and high-cost non-communicable diseases on the other. The parliamentary panel’s recommendation reflects that growing concern.
According to the committee’s observations, India’s health financing challenge remains acute despite progress in coverage expansion. A large share of medical spending in the country still comes directly from households rather than through pooled insurance or public provisioning. This means that even when families are nominally covered by a government scheme, they may still spend substantial amounts on diagnostics, medicines, follow up consultations, transport, caregiver support, consumables not fully reimbursed by hospitals, or treatment packages that exceed the approved rates.
The proposal to double the insurance limit to ₹10 lakh is therefore being viewed as an attempt to align public health protection with present day treatment realities. In practical terms, such an increase could provide greater financial room for managing complex illnesses that often require multiple hospital admissions or high cost interventions. These include organ related conditions, advanced cancer therapies, trauma care, neonatal intensive treatment, complicated cardiac procedures, and severe neurological cases where a single episode of hospitalisation can consume a large share of the existing entitlement.
The committee’s intervention also draws attention to a structural problem within Indian healthcare financing: the uneven relationship between health need and health affordability. Even where government hospitals and publicly funded schemes exist, many patients continue to seek care in private facilities because of distance, overcrowding, limited speciality services, referral patterns, or perceived quality differences. In such settings, the cost of treatment can escalate quickly. For families with modest incomes, the difference between ₹5 lakh and ₹10 lakh in annual protection could be the difference between completing treatment and abandoning it midway.
Public health economists have long argued that financial risk protection is not merely about insuring the poor against hospital bills; it is also about preventing illness from triggering long-term economic decline. A serious medical event can force households to liquidate savings, borrow at high interest, mortgage assets, or withdraw children from education. In rural and semi-urban households, a major health shock can push families into debt for years. In urban informal households too, even one prolonged illness can destabilise livelihoods. Seen through that lens, the committee’s recommendation goes beyond a technical insurance adjustment and speaks to the larger objective of social protection.
The timing of the recommendation is significant. India’s healthcare system is under pressure from multiple directions—rising non-communicable disease prevalence, ageing populations in some regions, expensive new therapies, post-pandemic stress on public health infrastructure, and persistent inequalities in access between states and districts. At the same time, health inflation has become a growing concern. Costs associated with hospitalisation, specialist consultations, advanced imaging, implants, and long-term disease management have risen over the years, placing renewed strain on both public schemes and private household budgets.
If the Centre accepts the recommendation, it would have substantial fiscal and administrative implications. Expanding the coverage limit would require a careful reassessment of premium structures, package rates, claims management, empanelment oversight, fraud control systems, and the financial burden-sharing model between the Union and the states. Since PM-JAY is implemented through a mix of trust and insurance models depending on the state, any enhancement in coverage would likely need corresponding adjustments in financing arrangements and reimbursement architecture.
That said, the proposal may also open the door to a deeper redesign of the scheme rather than a simple numerical increase. Health policy specialists often point out that the effectiveness of insurance cover is determined not only by the headline amount but by what is actually covered, how hospitals behave, how quickly claims are settled, whether patients face hidden charges, and how smoothly referral pathways work between primary, secondary and tertiary levels. In many instances, beneficiaries encounter confusion over package eligibility, exclusions, pre-authorisation, or follow-up care. A higher cover ceiling, while valuable, would not by itself resolve these operational issues unless accompanied by tighter implementation and patient protection mechanisms.
Another important dimension of the debate is whether public health resources should be concentrated more heavily on hospital insurance or more broadly across the continuum of care, including primary care, diagnostics, preventive services and chronic disease management. Ayushman Bharat itself was conceived as a two-part strategy—financial protection through PM-JAY and the creation of Health and Wellness Centres to strengthen comprehensive primary healthcare. Experts have repeatedly stressed that insurance alone cannot produce better health outcomes if people continue to reach hospitals late, with undiagnosed disease, poorly controlled diabetes, untreated hypertension, malnutrition or weak preventive care. The parliamentary recommendation, therefore, may revive discussion on how India balances hospital financing with front-end health system strengthening.
Even so, the symbolic importance of the panel’s proposal is considerable. It signals official recognition that the present level of financial protection may no longer match the burden of modern healthcare costs. It also reflects a growing policy emphasis on cushioning households against medical impoverishment at a time when access to healthcare has become central to broader welfare politics.
The recommendation could also trigger state-level demands for recalibration of their own health assurance schemes. Several states run parallel or supplementary insurance models with varying coverage levels, package structures and beneficiary categories. A decision by the Centre to increase PM-JAY cover may encourage some states to harmonise or enhance their schemes, while others may seek greater fiscal support to absorb the added burden. Much will depend on the eventual design of the proposal and the willingness of both the Union and states to share the financial commitment.
From the patient’s perspective, the debate over raising the cover limit is ultimately about security. For families living on uncertain incomes, healthcare costs remain among the most destabilising financial risks. A stronger insurance safety net could improve treatment continuity, reduce distress borrowing and make higher-end care more accessible. But the quality of implementation will be crucial. Patients need assurance not just that a higher entitlement exists on paper, but that hospitals will honour it, that packages will be sufficient, and that care will remain available without informal charges or administrative hurdles.
The committee’s recommendation also arrives at a time when India is trying to define the next phase of its health system expansion. The past decade has seen increased attention to insurance-led access, digital health, disease surveillance, immunisation strengthening and medical infrastructure growth. The next phase may require sharper focus on financial depth, continuity of care, health workforce distribution and quality assurance. Doubling Ayushman Bharat cover, if pursued, could become one of the most visible markers of that transition.
Whether the proposal is adopted immediately or taken up in stages, it has already shifted the policy conversation. It has placed affordability back at the centre of healthcare reform and underlined the fact that insurance adequacy matters as much as insurance enrolment. For millions of households navigating an increasingly expensive health environment, that distinction could prove decisive.
In the coming weeks, attention will turn to the government’s response and whether the recommendation finds a place in the next round of healthcare policy planning. If it does, the move could mark one of the most consequential adjustments to India’s public health protection framework since Ayushman Bharat was launched one aimed not merely at widening coverage, but at making that coverage meaningfully capable of absorbing the real cost of illness.